Department of Microbiology, La Trobe University, VIC, Australia.
Semin Cell Dev Biol. 2011 Feb;22(1):120-30. doi: 10.1016/j.semcdb.2010.11.004. Epub 2010 Dec 1.
Mitochondrial diseases are a diverse family of genetic disorders caused by mutations affecting mitochondrial proteins encoded in either the nuclear or the mitochondrial genome. By impairing mitochondrial oxidative phosphorylation, they compromise cellular energy production and the downstream consequences in humans are a bewilderingly complex array of signs and symptoms that can affect any of the major organ systems in unpredictable combinations. This complexity and unpredictability has limited our understanding of the cytopathological consequences of mitochondrial dysfunction. By contrast, in Dictyostelium the mitochondrial disease phenotypes are consistent, measurable "readouts" of dysregulated intracellular signalling pathways. When the underlying genetic defects would produce coordinate, generalized deficiencies in multiple mitochondrial respiratory complexes, the disease phenotypes are mediated by chronic activation of an energy-sensing protein kinase, AMP-activated protein kinase (AMPK). This chronic AMPK hyperactivity maintains mitochondrial mass and cellular ATP concentrations at normal levels, but chronically impairs growth, cell cycle progression, multicellular development, photosensory and thermosensory signal transduction. It also causes the cells to support greater proliferation of the intracellular bacterial pathogen, Legionella pneumophila. Notably however, phagocytic and macropinocytic nutrient uptake are impervious both to AMPK signalling and to these types of mitochondrial dysfunction. Surprisingly, a Complex I-specific deficiency (midA knockout) not only causes the foregoing AMPK-mediated defects, but also produces a dramatic deficit in endocytic nutrient uptake accompanied by an additional secondary defect in growth. More restricted and specific phenotypic outcomes are produced by knocking out genes for nuclear-encoded mitochondrial proteins that are not required for respiration. The Dictyostelium model for mitochondrial disease has thus revealed consistent patterns of sublethal dysregulation of intracellular signalling pathways that are produced by different types of underlying mitochondrial dysfunction.
线粒体疾病是一组由影响核或线粒体基因组中编码的线粒体蛋白的突变引起的遗传疾病。它们通过损害线粒体氧化磷酸化,影响细胞能量产生,在人类中导致一系列令人困惑的复杂症状和体征,这些症状和体征可影响任何主要器官系统,并以不可预测的组合出现。这种复杂性和不可预测性限制了我们对线粒体功能障碍的细胞病理学后果的理解。相比之下,在粘菌中,线粒体疾病表型是失调的细胞内信号通路的一致、可测量的“读出”。当潜在的遗传缺陷会导致多个线粒体呼吸复合物的协调、普遍缺乏时,疾病表型是由能量感应蛋白激酶 AMP 激活蛋白激酶(AMPK)的慢性激活介导的。这种慢性 AMPK 过度活跃可维持线粒体质量和细胞内 ATP 浓度正常,但会慢性损害生长、细胞周期进程、多细胞发育、感光和热敏信号转导。它还使细胞支持胞内细菌病原体军团菌的更大增殖。然而值得注意的是,吞噬作用和巨胞饮营养摄取既不受 AMPK 信号转导的影响,也不受这些类型的线粒体功能障碍的影响。令人惊讶的是,复合物 I 特异性缺陷(midA 敲除)不仅会导致前述的 AMPK 介导的缺陷,还会导致内吞营养摄取的急剧减少,同时伴有生长的额外次要缺陷。敲除不需要呼吸的核编码线粒体蛋白的基因会产生更具限制性和特异性的表型结果。因此,粘菌的线粒体疾病模型揭示了不同类型的线粒体功能障碍产生的细胞内信号通路的一致的亚致死失调模式。